Trip.com Group Initiates Management Trial for "No-Questions-Asked Personal Leave" with Annual Cap of 45 Days

Deep News
04/07

Trip.com Group announced today that it will launch a one-year management experiment on "no-questions-asked personal leave" in select business units starting May 1, 2026. The trial will employ a randomized controlled study methodology. Approximately 6,000 employees will be randomly assigned to either an "experimental group" or a "control group." During the trial period, employees in the experimental group will receive an additional annual allowance of up to 45 days of "no-questions-asked personal leave," on top of existing paid leave entitlements. Employees within the group may apply to use this leave at any time based on personal needs, without having to provide specific reasons. It is important to note that compensation and attendance policies during "no-questions-asked personal leave" will align with the company’s current personal leave system, with the key difference being the "no-questions-asked" aspect, emphasizing greater employee autonomy. The company aims to explore how granting employees greater discretion and trust over their working hours, amid increasing digital and intelligent tool adoption, may impact individual performance and organizational vitality. The company believes that increasing individuals’ discretionary leisure time is significant for enhancing personal, family, and societal well-being, as well as fostering innovation. As an important part of society, enterprises have a responsibility to engage in practical exploration. Efforts such as hybrid work arrangements, a 50,000-yuan childbirth benefit, and this new "no-questions-asked personal leave" trial represent steps to translate this philosophy into concrete practice.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10